- The shares of Tilray Inc (NASDAQ: TLRY) have received a price target decrease from $30.25 to $22. These are the details.
The shares of Tilray Inc (NASDAQ: TLRY) have received a price target decrease from $30.25 to $22. And Cantor Fitzgerald analyst Pablo Zuanic upgraded Tilray to an “Overweight” rating from a Neutral rating.
Cantor Fitzgerald analyst Pablo Zuanic assumed coverage of Tilray following a merger with Aphria. Aphria has been one of the best performers in Canada and Tilray had surpassed many of its peers in the export cannabis market. And no other licensed producer can make these combined claims as pointed out by Zuanic.
Zuanic believes that the Canadian licensed producer group – which is down about 50% since its peak on February 10 is expected to see favorable tailwinds in the months going forward. This will be driven by consumer demand recovery post-COVID and deregulation in the U.S.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.